European Surveillance of Antibiotic Resistance (ESAR)

A Study of the European Society of Biomodulation and Chemotherapy

Previous ] Results overview ]

Evaluation as causative Number of isolates
n %
Not causative 37 1.4%
Possible 667 25.5%
Probable 295 11.3%
Definite 1,172 44.8%
Surveillance 413 15.8%
<missing> 33 1.3%
Sum: 2,617 100.0%

 

Where acquired Number of isolates
n %
Hospital 1,933 73.9%
Community 533 20.4%
Abroad 103 3.9%
<missing> 48 1.8%
Sum: 2,617 100.0%

 

Beta-lactamasis
(not required for most specimen)

Number of isolates

n % from total % from tested
negative 180 6.9% 25.8%
positive 269 10.3% 38.5%
extended spectrum positive 249 9.5% 35.7%
Total tested 698 26.7% 100.0%
not tested 1,919 73.3%  
Sum: 2,617 100.0%  


Previous ] Results overview ]


© ESBiC Datacenter Munich, 2001